Navigating Civil Standing Requirements for Defense Success — RICO Report Podcast
Supreme Court to Settle Circuit Split Regarding RICO Damages Arising From Personal Injuries — RICO Report Podcast
RICO Vicarious Liability — RICO Report Podcast
RICO Damages — RICO Report Podcast
AGG Talks: Antitrust and White-Collar Crime Roundup - Breaking Down Ongoing Litigation Against Trump and Colorado’s Primary Ballot
RICO Lawsuit Against Shein — RICO Report Podcast
RICO and Foreign Arbitration Enforcement - RICO Report Podcast
State RICO Statutes - RICO Report Podcast
Unlawful Debt Collection Claims - RICO Report Podcast
Mail and Wire Fraud Claims - RICO Report Podcast
Defining the RICO Racketeering Element - RICO Report Podcast
The “Pattern” of Racketeering Activity - Regulatory Oversight Podcast
The "Pattern" of Racketeering Activity - RICO Report Podcast
Understanding the RICO Enterprise Requirement - RICO Report Podcast
The Intersection of RICO, Trade Secrets, and the Defend Trade Secrets Act - RICO Report Podcast
RICO Conduct (18 U.S.C. §§ 1962(a-d)) - RICO Report Podcast
The Justice Insiders: FIFA Corruption Trial – Will the Feds Score Another Goal?
Second Circuit Decision Potentially Broadens RICO Proximate Cause Element - RICO Report Podcast
Introduction to RICO: What You Need to Know - RICO Report Podcast
Anatomy of a Successful Motion to Dismiss in RICO Case
A federal district court recently decided that private litigants may proceed in a Racketeer Influenced and Corrupt Organization Act (RICO) lawsuit predicated on violations of the Anti-Kickback Statute (AKS). The plaintiffs...more
On July 10, 2020, in United States v. Ruan, the Eleventh Circuit affirmed the convictions of two Alabama doctors for running an opiate “pill mill.” Among many other things, the government charged that the doctors used...more
On October 22, 2019, Skadden hosted our Ninth Annual Pharmaceutical and Medical Device Enforcement and Litigation Seminar in New York, which focused on U.S. enforcement issues companies face throughout the industry. The key...more
Opioid manufacturers, distributors, pharmacies and prescribers are facing a deluge of lawsuits that involve criminal and civil claims in both federal and state courts. On May 2, 2019, a federal jury in Boston, Massachusetts,...more
Overview of Qui Tam Activity - We identified 49 health care-related qui tam cases that were unsealed in September and October 2018. The government intervened in whole or in part in 10 of those 49 unsealed cases, which...more
This latest installment of the Health Care Enforcement Quarterly Roundup reflects on trends that persisted in 2018 and those emerging trends that will carry us into 2019 and beyond. Leading off with the US Department of...more
Recently the U.S. Department of Justice (DOJ) issued a statement that it had intervened in a False Claims Act (FCA) case against Insys Therapeutics, Inc. and consolidated five separate qui tam cases into one case, U.S. ex rel...more
The government’s FCA enforcement efforts have continued to focus on key areas concerning the pharmaceutical and medical device industries. In fact, drug and device manufacturers accounted for nearly half of the enforcement...more